The left ventricular expression of the pro-hypertrophic myocyte enhancer factor 2 C (Mef2c) and myocyte enhancer factor 2D (Mef2d) did not increase in the CKD group as compared to the sham group (Table 4). This evidence concerns the gene MEF2C and chronic kidney disease.